Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies
Pharmaceutics · 12.10.2024 · 16 (10) · 1325
DOI: 10.3390/pharmaceutics16101325 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 12.10.2024. Verfasst von Bhupendra Raj Giri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 286 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Eye disorders affect a substantial portion of the global population, yet the availability of efficacious ophthalmic drug products remains limited. This can be partly ascribed to a number of factors: (1) inadequate understanding of physiological barriers, treatment strategies, drug and polymer properties, and delivery systems; (2) challenges in effectively delivering drugs to the anterior and posterior segments of the eye due to anatomical and physiological constraints; and (3) manufacturing and regulatory hurdles in ocular drug product development. The present review discusses innovative ocular delivery and treatments, encompassing implants, liposomes, nanoparticles, nanomicelles, microparticles, iontophoresis, in situ gels, contact lenses, microneedles, hydrogels, bispecific antibodies, and gene delivery strategies. Furthermore, this review also introduces advanced manufacturing technologies such as 3D printing and hot-melt extrusion (HME), aimed at improving bioavailability, reducing therapeutic dosages and side effects, facilitating the design of personalized ophthalmic dosage forms, as well as enhancing patient compliance. This comprehensive review lastly offers insights into digital healthcare, market trends, and industry and regulatory perspectives pertaining to ocular product development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.
- School of Pharmacy, The University of Mississippi, University, MS 38677, USA.
- Synthetic Product Development, Alexion, AstraZeneca Rare Disease, 101 College Street, New Haven, CT 06510, USA.
ORCID-Profile: Bhupendra Raj Giri, Vineet R Kulkarni
Zitieren
APA
Giri, B. R., Jakka, D., Sandoval, M. A., Kulkarni, V. R., & Bao, Q. (2024). Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics, 16(10), 1325. https://doi.org/10.3390/pharmaceutics16101325
Vancouver
Giri BR, Jakka D, Sandoval MA, Kulkarni VR, Bao Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics. 2024;16(10):1325. doi:10.3390/pharmaceutics16101325
BibTeX
@article{Giri2024,
author = {Giri, Bhupendra Raj and Jakka, Deeksha and Sandoval, Michael A and Kulkarni, Vineet R and Bao, Quanying},
title = {Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {10},
pages = {1325},
doi = {10.3390/pharmaceutics16101325}
}
EUVIMED